Bringing More Controllability to Cell Therapies

The all or nothing nature of the risk in a biotech company like that concentrates the mind. A project about controllable Carti transgens, you could very easily imagine somebody in a pharma company working on something like that. For this kind of innovation, because those problems aren't existential for the people at the pharma company, it's easier to move on to something else.